Tiziana Life Sciences
TLSA
24 hedge funds and large institutions have $12.9M invested in Tiziana Life Sciences in 2020 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 6 closing their positions.
126% more call options, than puts
Call options by funds: $70K | Put options by funds: $31K
67% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 6
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
9% more funds holding
Funds holding: 22 → 24 (+2)
1.4% more ownership
Funds ownership: 5.18% → 6.58% (+1.4%)
28% less capital invested
Capital invested by funds: $18M → $12.9M (-$5.11M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$423K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$190K |
| 3 |
D.E. Shaw & Co
New York
|
+$132K |
| 4 |
VF
Virtu Financial
New York
|
+$105K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$79K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HAG
HighPoint Advisor Group
Downers Grove,
Illinois
|
-$1.34M |
| 2 |
Morgan Stanley
New York
|
-$124K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$117K |
| 4 |
WS
Wedbush Securities
Los Angeles,
California
|
-$57K |
| 5 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$19.6K |
TLSA Hedge Fund Activity: Q4 2020 in Review
24 of the 5,677 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q4 2020, worth a combined $12.9M — down 28% from $18M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new TLSA positions and 6 closed out — a net gain of 2 holders — while 10 added to existing stakes and 6 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $423K. The largest seller was HighPoint Advisor Group, exiting entirely with an estimated $1.34M sold.
- 24 institutional investors held Tiziana Life Sciences (TLSA) as of Q4 2020, up from 22 in Q3 2020.
- Funds reported $12.9M of Tiziana Life Sciences stock for Q4 2020, down 28% quarter-over-quarter.
- 8 funds opened new Tiziana Life Sciences positions in Q4 2020 and 6 closed out, a net change of +2 holders.
- The largest Tiziana Life Sciences buyer in Q4 2020 was Renaissance Technologies, an estimated $423K added.
- The largest Tiziana Life Sciences seller in Q4 2020 was HighPoint Advisor Group, an estimated $1.34M sold.
Based on aggregated 13F filings for Q4 2020.